Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:32 am
Author: Getaka|Social: XLinkedIn

Quick Heal Technologies Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹57.19Overvalued by 60.28%vs CMP ₹144.00

P/E (135.0) × ROE (0.6%) × BV (₹82.40) × DY (2.00%)

₹41.13Overvalued by 71.44%vs CMP ₹144.00
MoS: -250.1% (Negative)Confidence: 63/100 (Moderate)Models: 1 Fair, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹33.9722%Over (-76.4%)
Graham NumberEarnings₹44.3316%Over (-69.2%)
Earnings PowerEarnings₹13.6111%Over (-90.5%)
DCFCash Flow₹10.9413%Over (-92.4%)
Net Asset ValueAssets₹82.447%Over (-42.8%)
EV/EBITDAEnterprise₹8.879%Over (-93.8%)
Earnings YieldEarnings₹10.607%Over (-92.6%)
ROCE CapitalReturns₹133.359%Fair (-7.4%)
Revenue MultipleRevenue₹77.645%Over (-46.1%)
Consensus (9 models)₹41.13100%Overvalued
Key Drivers: EPS CAGR -40.6% drags value — could be higher if earnings stabilize. | P/E of 135 makes PE-ROE unreliable — asset/earnings models are better benchmarks.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -40.6%

*Investments are subject to market risks

Investment Snapshot

38
Quick Heal Technologies Ltd scores 38/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health58/100 · Moderate
ROCE 0.2% WeakROE 0.6% WeakD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money30/100 · Weak
FII holding down -1.58% (6mo) SellingPromoter holding at 71.5% Stable
Earnings Quality30/100 · Weak
OPM contracting (16% → 2%) DecliningWorking capital: 354 days Capital intensive
Quarterly Momentum35/100 · Weak
Revenue (4Q): -6% YoY DecliningProfit (4Q): -74% YoY DecliningOPM: 0.6% (up 6.0% YoY) Margin expansion
Industry Rank20/100 · Weak
P/E 135.0 vs industry 98.1 In-lineROCE 0.2% vs industry 14.9% Below peersROE 0.6% vs industry 21.0% Below peers3Y sales CAGR: -6% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:32 am

Market Cap 779 Cr.
Current Price 144
Intrinsic Value₹41.13
High / Low 417/125
Stock P/E135
Book Value 82.4
Dividend Yield0.00 %
ROCE0.24 %
ROE0.63 %
Face Value 10.0
PEG Ratio-3.32

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Quick Heal Technologies Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Quick Heal Technologies Ltd 779 Cr. 144 417/125135 82.40.00 %0.24 %0.63 % 10.0
Innovana Thinklabs Ltd 724 Cr. 350 650/29215.5 1260.00 %25.6 %22.9 % 10.0
Take Solutions Ltd 598 Cr. 40.4 49.9/7.262,989 1.730.00 %11.2 %644 % 1.00
Xchanging Solutions Ltd 592 Cr. 53.1 105/47.510.2 32.93.76 %15.4 %13.9 % 10.0
IZMO Ltd 968 Cr. 647 1,380/25926.0 2540.00 %7.98 %7.03 % 10.0
Industry Average17,316.11 Cr418.4898.13120.780.77%14.90%21.00%6.77

All Competitor Stocks of Quick Heal Technologies Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 66.8049.2851.4478.3681.9280.0370.2973.4970.6165.1457.2383.5271.54
Expenses 78.1765.4566.5267.3970.3069.9967.7070.4274.3873.6266.9674.2971.09
Operating Profit -11.37-16.17-15.0810.9711.6210.042.593.07-3.77-8.48-9.739.230.45
OPM % -17.02%-32.81%-29.32%14.00%14.18%12.55%3.68%4.18%-5.34%-13.02%-17.00%11.05%0.63%
Other Income 3.4710.064.735.694.156.825.065.204.915.605.754.388.95
Interest 0.000.000.000.000.000.130.050.050.060.060.060.050.06
Depreciation 4.173.732.933.253.243.182.793.153.393.632.963.283.59
Profit before tax -12.07-9.84-13.2813.4112.5313.554.815.07-2.31-6.57-7.0010.285.75
Tax % -23.03%-32.52%-3.92%3.80%19.71%-3.62%16.22%18.15%-104.76%-50.53%-21.29%23.05%-14.96%
Net Profit -9.29-6.64-12.7612.9010.0614.044.034.150.11-3.25-5.517.916.61
EPS in Rs -1.75-1.25-2.402.431.892.620.750.770.02-0.60-1.021.461.22

Last Updated: February 4, 2026, 12:16 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 12:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 243286302300318315286333342278292280277
Expenses 157194200210198187195192235276274286286
Operating Profit 85921029012012892141107218-7-9
OPM % 35%32%34%30%38%41%32%42%31%1%6%-2%-3%
Other Income 1181025303331241922212125
Interest 0000000000000
Depreciation 11202431272422191716131313
Profit before tax 8680888412313710114610982612
Tax % 32%33%34%37%33%33%27%27%23%20%8%-404%
Net Profit 585458538392741078362456
EPS in Rs 9.568.818.277.5911.7913.0111.5916.6614.341.214.530.931.06
Dividend Payout % 78%85%30%33%25%15%35%24%31%207%66%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-6.90%7.41%-8.62%56.60%10.84%-19.57%44.59%-22.43%-92.77%300.00%-79.17%
Change in YoY Net Profit Growth (%)0.00%14.30%-16.03%65.22%-45.76%-30.41%64.16%-67.02%-70.34%392.77%-379.17%

Quick Heal Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:0%
5 Years:0%
3 Years:-6%
TTM:-14%
Compounded Profit Growth
10 Years:-21%
5 Years:-41%
3 Years:-60%
TTM:-111%
Stock Price CAGR
10 Years:%
5 Years:19%
3 Years:11%
1 Year:-59%
Return on Equity
10 Years:9%
5 Years:8%
3 Years:2%
Last Year:1%

Last Updated: September 5, 2025, 12:50 pm

Balance Sheet

Last Updated: January 7, 2026, 4:16 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 61617070707164645853545454
Reserves 271270559592653719580687570367383387392
Borrowings 0000000000000
Other Liabilities 47978872576352758874768399
Total Liabilities 380428717734781853697827716493513525545
Fixed Assets 82111142185173165158146137124117119117
CWIP 5574551414113200309
Investments 131130115182306390310416318198190179185
Other Assets 111113405353287288225263261171203226234
Total Assets 380428717734781853697827716493513525545

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 6177783694617199803118-22
Cash from Investing Activity + -59-53-163-73-122-37148-92126185616
Cash from Financing Activity + -2-18189-20-19-24-2210-214-2122-10
Net Cash Flow -17104-57-471-36-9426-17
Free Cash Flow -161142280546090793212-36
CFO/OP 119%116%92%73%100%91%114%90%106%2,064%102%325%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow85.0092.00102.0090.00120.00128.0092.00141.00107.002.0018.00-7.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 10483112118118145144165184161165218
Inventory Days 181144
Days Payable 8641,103
Cash Conversion Cycle 104-600-847118118145144165184161165218
Working Capital Days 52-232949709294981028388354
ROCE %27%24%18%14%18%18%14%21%15%0%6%0%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 73.08%73.08%73.06%72.76%72.48%72.44%72.08%71.92%71.82%71.79%71.63%71.54%
FIIs 2.04%2.02%1.56%1.66%1.65%1.54%1.61%1.81%2.03%1.16%0.50%0.45%
DIIs 0.00%0.00%1.13%1.44%2.06%2.41%2.62%2.84%2.63%2.58%2.33%2.29%
Public 24.89%24.91%24.23%24.13%23.81%23.61%23.68%23.42%23.52%24.46%25.53%25.73%
No. of Shareholders 65,11963,44557,52850,24946,92346,79947,78147,72049,83753,85655,91056,030

Shareholding Pattern Chart

No. of Shareholders

Quick Heal Technologies Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Tata Digital India Fund 425,000 0.07 7.97N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.944.561.1414.0116.66
Diluted EPS (Rs.) 0.914.481.1413.9416.65
Cash EPS (Rs.) 3.336.884.2217.3419.70
Book Value[Excl.RevalReserv]/Share (Rs.) 81.7581.6779.09108.19117.04
Book Value[Incl.RevalReserv]/Share (Rs.) 81.7581.6779.09108.19117.04
Revenue From Operations / Share (Rs.) 51.7654.5252.4058.9451.87
PBDIT / Share (Rs.) 2.637.284.5221.7325.80
PBIT / Share (Rs.) 0.224.921.5118.7322.76
PBT / Share (Rs.) 0.184.901.5118.7322.76
Net Profit / Share (Rs.) 0.934.531.2114.3416.66
NP After MI And SOA / Share (Rs.) 0.934.531.2114.3416.66
PBDIT Margin (%) 5.0713.348.6336.8749.73
PBIT Margin (%) 0.439.022.8831.7843.87
PBT Margin (%) 0.358.982.8831.7843.87
Net Profit Margin (%) 1.808.302.3024.3332.12
NP After MI And SOA Margin (%) 1.808.302.3024.3332.12
Return on Networth / Equity (%) 1.145.541.5213.2514.23
Return on Capital Employeed (%) 0.275.991.9017.2519.41
Return On Assets (%) 0.954.721.2911.6212.94
Asset Turnover Ratio (%) 0.530.580.460.440.43
Current Ratio (X) 4.724.964.506.208.53
Quick Ratio (X) 4.694.934.436.158.49
Inventory Turnover Ratio (X) 111.370.110.230.240.21
Dividend Payout Ratio (NP) (%) 320.0354.74407.9627.850.00
Dividend Payout Ratio (CP) (%) 89.6136.02116.6123.030.00
Earning Retention Ratio (%) -220.0345.26-307.9672.150.00
Cash Earning Retention Ratio (%) 10.3963.98-16.6176.970.00
Interest Coverage Ratio (X) 64.45299.540.000.000.00
Interest Coverage Ratio (Post Tax) (X) 23.91187.460.000.000.00
Enterprise Value (Cr.) 1527.482480.96695.04966.921113.79
EV / Net Operating Revenue (X) 5.468.502.502.833.34
EV / EBITDA (X) 107.7263.7128.957.676.72
MarketCap / Net Operating Revenue (X) 5.548.632.543.013.60
Retention Ratios (%) -220.0345.25-307.9672.140.00
Price / BV (X) 3.515.761.681.641.59
Price / Net Operating Revenue (X) 5.548.632.543.013.60
EarningsYield 0.000.010.010.080.08

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Quick Heal Technologies Ltd. is a Public Limited Listed company incorporated on 07/08/1995 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200MH1995PLC091408 and registration number is 091408. Currently Company is involved in the business activities of Writing , modifying, testing of computer program to meet the needs of a particular client excluding web-page designing. Company's Total Operating Revenue is Rs. 279.53 Cr. and Equity Capital is Rs. 54.00 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
IT Consulting & SoftwareSolitaire Business Hub, Pune Maharashtra 411014Contact not found
Management
NamePosition Held
Dr. Kailash Sahebrao KatkarChairman & Managing Director
Dr. Sanjay Sahebrao KatkarJoint Managing Director
Mr. Shailesh LakhaniNon Executive Director
Mr. Amitabha MukhopadhyayIndependent Director
Air M'shal (Retd.) Bhushan Nilkanth GokhaleIndependent Director
Ms. Apurva Pradeep JoshiIndependent Director
Mr. Richard StiennonIndependent Director
Mr. Kamal Kumar AgarwalIndependent Director

FAQ

What is the intrinsic value of Quick Heal Technologies Ltd and is it undervalued?

As of 15 April 2026, Quick Heal Technologies Ltd's intrinsic value is ₹41.13, which is 71.44% lower than the current market price of ₹144.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (0.63 %), book value (₹82.4), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Quick Heal Technologies Ltd?

Quick Heal Technologies Ltd is trading at ₹144.00 as of 15 April 2026, with a FY2026-2027 high of ₹417 and low of ₹125. The stock is currently near its 52-week low. Market cap stands at ₹779 Cr..

How does Quick Heal Technologies Ltd's P/E ratio compare to its industry?

Quick Heal Technologies Ltd has a P/E ratio of 135, which is above the industry average of 98.13. The premium over industry average may reflect growth expectations or speculative interest.

Is Quick Heal Technologies Ltd financially healthy?

Key indicators for Quick Heal Technologies Ltd: ROCE of 0.24 % is on the lower side compared to the industry average of 14.90%; ROE of 0.63 % is below ideal levels (industry average: 21.00%). Dividend yield is 0.00 %.

Is Quick Heal Technologies Ltd profitable and how is the profit trend?

Quick Heal Technologies Ltd reported a net profit of ₹5 Cr in Mar 2025 on revenue of ₹280 Cr. Compared to ₹83 Cr in Mar 2022, the net profit shows a declining trend.

Does Quick Heal Technologies Ltd pay dividends?

Quick Heal Technologies Ltd has a dividend yield of 0.00 % at the current price of ₹144.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Quick Heal Technologies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports